recurrence

March 22, 2019

Low White Blood Cell Count May Help Predict Some Ovarian Cancer Outcomes

News

A reduced number of lymphocytes — one of the main types of immune cells — in advanced ovarian cancer patients before treatment is linked with a higher risk of disease ... Read more

March 26, 2018

Phase 1 Trial Finds TPIV200 Is Safe, Delays Recurrence in Ovarian, Breast Cancer

News

An investigational vaccine called TPIV200 was found to be safe and generated strong T-cell immunity against tumor cells, significantly delaying recurrence in breast and ovarian cancer patients who had achieved complete ... Read more

April 24, 2017April 24, 2017

World’s First Personalized Ovarian Cancer Vaccine Trial Recruits Patients at UConn Health

News

The University of Connecticut Health Center (UConn Health) is recruiting ovarian cancer patients for the world’s first clinical trial testing a personalized genomics-driven vaccine (NCT02933073). The vaccine, called OncoImmunome, targets women with ... Read more

August 3, 2016August 3, 2016

Specific Ovarian Cancer-tailored Immunotherapy Appears Effective in Mouse Models

News

Researchers at the Wistar Institute identified a new protein that is expressed on the surface of different types of ovarian cancer cells. This protein can therefore be targeted to treat ... Read more